Nadine Kalenda Kayiba
University of Kinshasa
10 Papers
5 Citations
Nadine Kalenda Kayiba is an academic researcher from University of Kinshasa. The author has contributed to research in topics: Malaria & Plasmodium falciparum. The author has an hindex of 3, co-authored 7 publications. Previous affiliations of Nadine Kalenda Kayiba include Université catholique de Louvain & Catholic University of Leuven.
Chat about Author
Papers
Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018-2019.
Doudou Malekita Yobi,Nadine Kalenda Kayiba,Nadine Kalenda Kayiba,Dieudonné Makaba Mvumbi,Raphaël Boreux,Pius Zakayi Kabututu,Hippolyte Situakibanza,Solange E. Umesumbu,Patrick De Mol,Niko Speybroeck,Georges Lelo Mvumbi,Marie-Pierre Hayette +11 more
TL;DR: In this paper, the presence of markers associated with resistance to the current first-line artemisinin-based combination therapy (ACT) in isolates of Plasmodium falciparum from treatment failure patients in the Democratic Republic of Congo was investigated.
The lack of K13-propeller mutations associated with artemisinin resistance in Plasmodium falciparum in Democratic Republic of Congo (DRC)
Doudou Malekita Yobi,Nadine Kalenda Kayiba,Nadine Kalenda Kayiba,Dieudonné Makaba Mvumbi,Raphaël Boreux,Sébastien Bontems,Pius Zakayi Kabututu,Patrick De Mol,Niko Speybroeck,Georges Lelo Mvumbi,Marie-Pierre Hayette +10 more
TL;DR: The pfk13-propeller gene polymorphism in clinical isolates of P. falciparum collected in the DRC calls for further investigations to assess their implication in drug resistance.
Malaria infection among adults residing in a highly endemic region from the Democratic Republic of the Congo
Nadine Kalenda Kayiba,Yuko Nitahara,Evariste Tshibangu-Kabamba,D. Mbuyi,Augustin Kabongo-Tshibaka,Nestor Tshituka Kalala,Barthélemy Mukenga Tshiebue,Katherine-Sofia Candray-Medina,Natsuko Kaku,Yu Nakagama,Niko Speybroeck,Dieudonné N Mumba,Ghislain Tumba Disashi,Akira Kaneko,Yasutoshi Kido +14 more
- 18 Mar 2024
TL;DR: In a highly endemic region of the Democratic Republic of Congo, 60.2% of adults had Plasmodium spp. infections, with Plasmodium falciparum being the most prevalent species, and socioeconomic disadvantage and age being significant predictors of infection.
7
The landscape of drug resistance in Plasmodium falciparum malaria in the Democratic Republic of Congo: a mapping systematic review
Nadine Kalenda Kayiba,Evariste Tshibangu-Kabamba,Angel Rosas-Aguirre,Natsuko Kaku,Yu Nakagama,Akira Kaneko,Dieudonné Mvumbi Makaba,Doudou Yobi Malekita,Brecht Devleesschauwer,Joris L. Likwela,Pius Kabututu Zakayi,P. Demol,G. Mvumbi Lelo,Marie-Pierre Hayette,Paul Lusamba Dikassa,Yasutoshi Kido,Niko Speybroeck +16 more
TL;DR: Drug resistance poses a serious threat to existing malaria therapies and chemoprevention options in the DRC and provides a baseline for monitoring public health efforts as well as evidence for decision-making in support of national malaria policies and for implementing regionally tailored control measures across the country.
2
Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance
Doudou Malekita Yobi,Nadine Kalenda Kayiba,Nadine Kalenda Kayiba,Dieudonné Makaba Mvumbi,Raphaël Boreux,Pius Zakayi Kabututu,Hippolyte Situakibanza,Joris L. Likwela,Patrick De Mol,Emile W. Okitolonda,Niko Speybroeck,Georges Lelo Mvumbi,Marie-Pierre Hayette +12 more
TL;DR: Overall, the frequency of the P. falciparum CQ resistance marker has decreased significantly and no resistance marker to AQ was detected in the DRC in 2017, however, the between regions variability of C Q resistance remains high in the country.